This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
$2999
The global corticosteroids market size was valued at USD 5.30 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.49% from 2024 to 2030. This is attributed to the rising geriatric population, increasing incidence of cancer, increasing healthcare expenditure, and healthcare awareness among the people. Corticosteroids are frequently recommended for reducing swelling and inflammation in and around tumors, which can help cancer patients experience less pain and function better.
Report Coverage & Deliverables
Competitive benchmarking
Historical data & forecasts
Company revenue shares
Regional opportunities
Latest trends & dynamics
Key Companies & Market Share Insights
Key players operating in the market are Pfizer Inc., Novartis AG, GSK plc., Merck KGaA, AstraZeneca, Cipla Inc., Abbott. The market participants are working towards new types of development, M&A activities, and other strategic alliances to gain new market avenues. The following are some instances of such initiatives.
In August 2022, in a pilot study examining vamorolone as a potential cure for BMD (Becker muscular dystrophy), the first patient was administered a dose of vamorolone. As a potential treatment for several kinds of muscular dystrophy, ReveraGen BioPharma started studying and developing steroid medicine.
In April 2022, Eli Lilly and Company combined Lebrikizumab and topical corticosteroids to treat atopic dermatitis (AD). During the 16th week of the trial conducted, 75% of improvement was observed among the patients. In these critical combination trials that met all primary and important secondary objectives, lebrikizumab significantly enhanced a number of areas crucial to those suffering from atopic dermatitis, including skin and itch.
The global corticosteroids market size was valued at USD 5.30 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.49% from 2024 to 2030. This is attributed to the rising geriatric population, increasing incidence of cancer, increasing healthcare expenditure, and healthcare awareness among the people. Corticosteroids are frequently recommended for reducing swelling and inflammation in and around tumors, which can help cancer patients experience less pain and function better.
Report Coverage & Deliverables
Competitive benchmarking
Historical data & forecasts
Company revenue shares
Regional opportunities
Latest trends & dynamics
Key Companies & Market Share Insights
Key players operating in the market are Pfizer Inc., Novartis AG, GSK plc., Merck KGaA, AstraZeneca, Cipla Inc., Abbott. The market participants are working towards new types of development, M&A activities, and other strategic alliances to gain new market avenues. The following are some instances of such initiatives.
In August 2022, in a pilot study examining vamorolone as a potential cure for BMD (Becker muscular dystrophy), the first patient was administered a dose of vamorolone. As a potential treatment for several kinds of muscular dystrophy, ReveraGen BioPharma started studying and developing steroid medicine.
In April 2022, Eli Lilly and Company combined Lebrikizumab and topical corticosteroids to treat atopic dermatitis (AD). During the 16th week of the trial conducted, 75% of improvement was observed among the patients. In these critical combination trials that met all primary and important secondary objectives, lebrikizumab significantly enhanced a number of areas crucial to those suffering from atopic dermatitis, including skin and itch.
RELATED PRODUCTS
Steroids Market, By Type (Corticosteroids, Sex Hormones), By Modes of Administration (Oral, Injection, Topical [Creams and Gels], Skin Patches, Inhalers), By Application (Anabolic, Androgenic, Other), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region Forecast to 2028
Global Androgens and Anabolic Steroids Market Report 2024 Market Size Split by Modes of Administration (Oral, Injectables, Topical, Others), by Application (Anabolic, Androgenic, Others), by Ingredients etc.,
Corticosteroids Market Size, Share & Trends Analysis Report By Product (Glucocorticoids, Mineralocorticoids), By Route Of Administration, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2030